MediumEndocrinologyType 2 diabetes with cardiovascular diseaseau-racpau-amc
A 62-year-old man with type 2 diabetes, chronic kidney disease (eGFR 50 mL/min/1.73 m²) and a recent non-ST-elevation myocardial infarction is already on maximum tolerated metformin and ACE inhibitor therapy. His HbA1c is 7.5%. What additional glucose-lowering agent is MOST appropriate to reduce his cardiovascular and renal risk?